Neuroendocrine Tumors: Prognostic Factors and Life Expectancy in Neuroendocrine Carcinoma Survival

Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms originating from neuroendocrine cells capable of hormone production. Although considered rare, their incidence has increased in recent decades, leading to a growing interest in understanding the neuroendocrine tumor prognosis and the associated life expectancy of these neoplasms [1]. This article explores recent advances in identifying factors influencing the prognosis and survival of patients with NETs.

Prognostic Factors in Neuroendocrine Tumors

The identification of endocrine prognostic factors is crucial for the clinical management of NETs. Among the most relevant factors are histological grade, tumor stage, and the presence of metastases. Recent studies have highlighted the importance of classification and histological grade in predicting long-term NET survival [2]. Additionally, the location of the primary tumor and the presence of liver metastases are critical determinants in the prognosis of patients [3].

The use of biomarkers and nomogram models has improved the ability to predict cancer-specific survival in patients with NETs. These models integrate multiple clinical and pathological variables, providing a valuable tool for personalized clinical decision-making [4]. Surgery remains a key component in the treatment of NETs, especially in those with limited malignant potential, such as small pancreatic neuroendocrine tumors [5].

Conclusions

Neuroendocrine tumors present a clinical challenge due to their heterogeneity and variable biological behavior. The identification of precise prognostic factors is essential to improve NET survival and optimize treatment strategies. As research advances, the use of predictive models and specific biomarkers promises to enhance the accuracy of prognosis and the quality of life for patients with NETs. Integrating these advances into daily clinical practice is fundamental to addressing the complexities of these hormone-origin neoplasms.

Referencias

• [1] One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.
• [2] Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies.
• [3] Two machine learning-based nomogram to predict risk and prognostic factors for liver metastasis from pancreatic neuroendocrine tumors: a multicenter study.
• [4] Incidence, survival, and prognostic nomogram of patients with small intestinal neuroendocrine tumors: A SEER population-based study.
• [5] Clinicopathological characteristics, survival outcomes and prognostic factors in the cT1N0M0 pancreatic neuroendocrine tumors: A SEER-based study.

Created 14/1/2025